February 13, 2019 Another knock back for urea cycle disorders Curevac’s decision to exit work on an mRNA approach to OTC deficiency follows a clinical hold on Translate Bio’s similar project, and raises broader concerns.
August 06, 2018 Regenerating insulin-producing cells the next big thing in diabetes Novo Nordisk's cell therapy collaborations are a sign that serious work is under way.
November 09, 2009 EP Vantage Interview - ACT heads for the clinic with second stem cell-based therapy
